Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT05306548 Recruiting - Clinical trials for Carpal Tunnel Syndrome

A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome

NOR-CACTUS
Start date: April 8, 2022
Phase: Phase 4
Study type: Interventional

Carpal tunnel syndrome (CTS) causes numbness and pain in the hand and arm, and is an important cause of work absence and disability. The aim of the NOR-CACTUS Trial is to compare outcomes of a treatment strategy where the initial treatment is up to two ultrasound-guided corticosteroid injections, followed by scheduled clinical assessment of treatment effect, and subsequent surgery if needed, to a treatment strategy where surgery is the first-line treatment. Participants will be randomized to one of the treatment strategies, and followed up for two years after start of the study intervention. Outcomes will include patient-reported, clinical, functional and neurophysiological measures, and health-economic aspects. The hypothesis of the study is that there is no difference between the two treatment groups in the percentage of patients with a satisfactory symptom relief (treatment success) one year after the initial therapeutic intervention.

NCT ID: NCT05306080 Recruiting - HLH Clinical Trials

Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome

Start date: April 17, 2022
Phase: Early Phase 1
Study type: Interventional

This is a pilot, open-label study to assess the safety and feasibility of using investigational drug(s) as rescue therapies for CAR T cell related CRS and HLH-like syndrome (CRHLS).

NCT ID: NCT05306002 Completed - DNA Damage Clinical Trials

Nutritional Intervention and DNA Damage of Patients With HBOC

Start date: November 28, 2017
Phase: N/A
Study type: Interventional

Breast and Ovarian Cancer Syndrome (HBOC) is characterized by mutations in tumor suppressor genes such as BRCA1 and BRCA2, which increase the carrier's risk of developing breast and ovarian cancer, especially before 40. In this pathology the DNA damage is increased because there is a state of chronic inflammation, plus the antineoplastic treatments and changes in body composition result in oxidative stress. The inductions of epigenetic changes by a nutritional intervention with an specific distribution of macronutrients, micronutrients and polyphenols, not only ensures an optimal nutritional status, but also shows a decrease in oxidative stress, and therefore in DNA damage. The aim of this study is to assess if the DNA damage in patients with HBOC decreases after the nutritional intervention.

NCT ID: NCT05305898 Recruiting - Clinical trials for Acute Coronary Syndrome

"MetCool ACS"- Metformin "Cooling" Effect on Metformin-naive Patients Treated With PCI Because of Acute Coronary Syndrome

Start date: February 8, 2022
Phase: Phase 3
Study type: Interventional

The aim of the study is the evaluation of the effect of metformin among the patients without diabetes, on the incidence of reintervention, unplanned revascularization, after full percutaneous coronary revascularization as a result of the first episode of the acute coronary syndrome (ACS).

NCT ID: NCT05305677 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Effect of NMN (Nicotinamide Mononucleotide) on Polycystic Ovary Syndrome

NMN
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to understand the effect of Nicotinamide mononucleotide (NMN) on patients with polycystic ovary syndrome.

NCT ID: NCT05305482 Recruiting - Clinical trials for Acute Coronary Syndrome

DCS Versus DES for One-month DAPT in Patients With ACS: ONE-PASS Trial

ONE-PASS
Start date: August 10, 2022
Phase: N/A
Study type: Interventional

To test whether the polymer-free drug-coated stent (DCS) BioFreedom is noninferior to the biodegradable polymer drug-eluting stent (DES) Ultimaster in terms of 1-year patient-oriented composite endpoint (POCE, composite of all-cause mortality, any MI, or any revascularization) in a setting of 1-month dual-antiplatelet therapy (DAPT) strategy (1-month DAPT followed ticagrelor monotherapy) after acute coronary syndrome.

NCT ID: NCT05305209 Not yet recruiting - Clinical trials for Genitourinary Syndrome of Menopause

Laser Therapy for Treatment of Genitourinary Syndrome of Menopause (GSM) in Postmenopausal Women

LASER_2022
Start date: July 1, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-centre, double blinded, randomized controlled trial, which will be conducted under a common protocol. The aim of this study is to evaluate the efficacy of vaginal laser for treatment of GSM (Genitourinary Syndrome of Menopause) compared to the sham procedure in postmenopausal women. The study population is female subjects > 18 years old with symptoms of genitourinary syndrome of menopause (GSM) who have not menstruated for at least 5 years.

NCT ID: NCT05304884 Completed - Clinical trials for Research on the Effectiveness of a Corticosteroid, Single Dose and Three Doses of Ozone Injection in Shoulder Impingement Syndrome

Ozone Injection for Shoulder Impengement Syndrome

Start date: June 30, 2021
Phase: Phase 4
Study type: Interventional

Ozone injection has lately been utilized as a safe alternative to corticosteroids in the management of musculoskeletal diseases with fewer side effects. This study aimed to compare the effectiveness of a corticosteroid, single dose and three doses of ozone injection in shoulder impingement syndrome (SIS).

NCT ID: NCT05303610 Not yet recruiting - Knee Clinical Trials

Effects of Tissue Properties of the Superficial Anterior Myofascial Chain on the Development of Patellofemoral Pain Syndrome

Start date: September 20, 2022
Phase:
Study type: Observational

The aim of the study is to evaluate the myofascial chain lines in addition to the general evaluation parameters in patients with patellofemoral pain syndrome (PFPS) and to determine whether deviations from normal in the myofascial structure have an effect on the development of PFPS. There will be two groups in this study. One of the groups will consist of 28 patients aged between 25-50 years. The other group will consist of 28 healthy individuals between the ages of 25-50 years. Postural problems that can be seen in the superficial anterior myofascial chain line will be evaluated. These problems: forward head, q-angle, genu varum, genu valgum, foot postural problems (pes planus, pes kavus vb.) and pelvic tilt. In addition to all these assessments, knee pain and the biomechanical properties of the anterior myofascial tissue will be evaluated.

NCT ID: NCT05302531 Recruiting - Clinical trials for Short Bowel Syndrome

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

GRAAL
Start date: December 9, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the drug absorption of oral antibiotics in patients with short bowel syndrome.